Is Amgen A Good Stock To Buy Review

The market is hyper-focused on MariTide , Amgen’s monthly-dose obesity candidate, which could disrupt the current weekly-dose market dominated by Eli Lilly and Novo Nordisk.

The company recently declared a $2.52 per share quarterly dividend, offering an attractive yield of approximately 2.9-3% . is amgen a good stock to buy

Amgen's appeal lies in its ability to generate massive cash flow while aggressively pivoting its portfolio to offset upcoming biosimilar competition. The Bull Case The market is hyper-focused on MariTide , Amgen’s